SARA CHIGLO: Open Payments
NPI 1346934866 · MEXIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 9 payments from 5 companies in 2025. Trend: 2023 $44 · 2024 $199 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $79 |
| Novo Nordisk Inc | 3 | $60 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, Ozempic, Wegovy, RotarexS 6 F x 135 cm, MOUNJARO, CAPLYTA, QULIPTA.
Industry payments across TX — which companies pay providers there.
